Antitrust and Competition

Why Most Advertisers Can’t Afford to Boycott Facebook

While big brands can afford to pause their addiction to Facebook, most advertisers cannot participate, as they have become so dependent on Facebook’s ad-targeting...

The United States: An Exceptional Case? A Webinar With Stephen Haber, Richard R. John, and Luigi Zingales

Many see the US as a land where free markets and antitrust enforcement have historically kept monopolies under control. But is that really the...

Regulators Turn Their Attention Towards Apple’s Exploitation of App Developers. Now What?

Congress could level the playing field for independent app developers by looking to regulatory templates in music. Last week, the European Commission announced it was...

At the Heart of the European Commission’s Investigations of Apple Is a Basic Question: How Should Apple Make Money?

Just like Spotify, Apple has amassed an installed base of users. Spotify sells its users to advertisers while Apple sells its users to app...

When Scholarship Turns Into Business: Stefano Feltri Responds to Paul Milgrom

Stefano Feltri responds to Paul Milgrom’s criticisms of his recent ProMarket piece on the 2017 FCC spectrum auction. In his response, Paul Milgrom discloses some...

Should We Leave Public Resource Allocation to the Experts? Glen Weyl Responds to Paul Milgrom

Glen Weyl, Microsoft’s Office of the Chief Technology Officer Political Economist and Social Technologist, responds to Paul Milgrom’s criticisms of his recent ProMarket piece...

Was the 2017 FCC Spectrum Auction a Success—or a Disappointing Failure?

In a post published on his company’s website, Stanford professor Paul Milgrom responded to the recent ProMarket pieces by Glen Weyl and Stefano Feltri...

AT&T’s Treatment of HBO Max Sparks Calls for Net Neutrality Rules. But Is Sector-Specific Regulation the Right Solution?

Not all forms of self-preferencing should be banned, but we do need a standard by which to evaluate allegations of anticompetitive self-preferencing. Congress should...

Covid-19 and Amazon’s Future: a Webinar With Stacy Mitchell, Steven Kaplan, and Jacob Schlesinger

As part of the Stigler Center’s Political Economy of Covid-19 Series of online programming, which explores the economic and political implications of Covid-19 with...

Paid to Show the Drug Works: Why “Blind” Clinical Trials for New Drugs are Far Less Blind Than They Should Be

New research shows that physicians in industry-sponsored trials are more captured by pharmaceutical companies than physicians in unsponsored ones. Economists love health care because it...

Latest news